In August 2023, the U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D for the first cycle of negotiations.

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs to have its price slashed in bargaining with the US government, a company executive said.

Sen. Bernie Sanders has been probing the high prices that Novo charges for Ozempic and Wegovy. Yesterday, he share that executives of major generic pharma companies told him they could make generic versions of Ozempic for less than $100 a month.

Sen. Bernie Sanders called out Novo Nordisk's high price of Ozempic and Wegovy for Americans as "excessive corporate greed." Sanders said he's spoken with CEOs of major generic pharmaceutical companies who say they can manufacture the same drug for less than $100 a month,